Read on to get our full commentary, or use the links below to jump to a specific area of interest: The national insurers financial performance in Q2 2025 was hurt by rising medical costs Insurers faced mounting pressures across Q2, reversing the signs of stabilization we saw in Q1 of this year
Andrejek, N., Fetner, T., & Heath, M
Dysmorphological and pharmacological studies in 4q- syndrome
In a pooled analysis of glycemic control trials, patients reported diabetic retinopathy related adverse reactions during the trial (4.2% with semaglutide tablets and 3.8% with comparator)
Although the percentage of patients using statins did not differ significantly between the two groups, the percentage tended to be lower in ALT responders than in ALT non-responders
Effects of oxidative stress induced by environmental relevant concentrations of fluoxetine on the embryonic development on Danio rerio